EUVIMED · CrossrefZeitschrift
Best Practice & Research Clinical Endocrinology & Metabolism
ISSN 1521-690X · Elsevier BV
Neueste Artikel
Refractory hypothyroidism
Factitious Hypocalcemia and Hypercalcemia
Lean metabolic dysfunction-associated steatotic liver disease: Current insights and knowledge gaps
Type 2 diabetes and obesity in South Asian patients with polyendocrine metabolic ovarian syndrome: The emerging role of metabolomics
Hyponatremia and bone pathophysiology: An integrated preclinical and clinical perspective
Special considerations of hyponatremia in the elderly patient
Diagnostic algorithm of hyponatremia
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment
Outcomes of pregnancies complicated by type 2 diabetes
Diagnosis of gestational diabetes: Evidence and pitfalls
Metabolic complications and their mechanisms in patients with craniopharyngioma
The epidemiology of disorders of sex development
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?
Broader impact and outcome of human NR5A1/SF1 variants
Clinical manifestations and treatment of hypopituitarism due to traumatic brain injury
The interplay between thyrotropic axis, neurological complications, and rehabilitation outcomes in patients with traumatic brain injury
Neuroendocrine changes during the acute phase following traumatic brain injury
Neuroendocrine dysfunction following traumatic brain injury: Current insights and emerging perspectives
Fluid and electrolyte disorders following traumatic brain injury
Pathophysiology and diagnosis of neuroendocrine abnormalities in patients with traumatic brain injury
Parathyroid carcinoma: New insights
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
Update on clinical characteristics in the evaluation of phaeochromocytoma and paraganglioma
Current views on the role of HIF-2α in the pathogenesis and syndromic presentation of pheochromocytoma and paraganglioma
Metabolic and cardiovascular risks of hormone treatment for transgender individuals
Testosterone and other treatments for transgender males and non-binary trans masculine individuals
The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals
Real-world value of cabergoline in the treatment of acromegaly
Treatment of acromegaly with oral octreotide
Growth hormone receptor antagonist pegvisomant and its role in the medical therapy of growth hormone excess
EUVIMED